<Insert Picture Here> Healthcare and Life Sciences Mission & Strategy. Leo Liang Vice President HSGBU Japan and APAC

Transcription

1 <Insert Picture Here> Healthcare and Life Sciences Mission & Strategy Leo Liang Vice President HSGBU Japan and APAC

2 The following is intended to outline our general product direction. It is intended for information purposes only, and may not be incorporated into any contract. It is not a commitment to deliver any material, code, or functionality, and should not be relied upon in making purchasing decisions. The development, release, and timing of any features or functionality described for Oracle s products remains at the sole discretion of Oracle.

3 Oracle Corporation World s largest enterprise software vendor Four product families Applications, Database, Middleware, and Infrastructure $22.4 billion revenue, FY08 325,000 global customers 85,000 employees Operating in 145 countries

4 Oracle s Leadership in Health Sciences 20 of the Top 20 Pharmaceutical Companies Use Oracle Applications to Run Their Business 8 of the Top 10 Contract Research Organizations Use Oracle Applications to Run Their Business 9 of the Top 10 Medical Device Companies Use Oracle Applications to Run Their Business 10 of the Top 10 Research Universities Use Oracle Applications to Run Their Business 10 of the Top 10 Healthcare Organizations Use Oracle Applications to Run Their Business

5 30 Years of R&D Innovation Total Recall SOA Suite Audit Vault R&D Spending, $B Apps Integration Arch 20% CAGR $2.7 Business Process Mgmt $2.2 Self-Managing Database $1.9 Grid Computing $1.5 Oracle Data Guard $1.3 Real Application Clusters First Comprehensive CRM Suite Flashback Query First Internet Applications FY04 FY05 FY06 FY07 FY08 Built-in Java VM Partitioning Support Full Applications Implementation Methodology Industry-Specific Business Applications Object Relational Support Multimedia Support Data Warehousing Optimizations First Unix-Based Applications Parallel Operation Distributed SQL & Transaction Support Cluster & MPP Support 1,500 Patents Multi-Version Read Consistency Client/Server Support 1,500 Patents in Progress Platform Portability Commercial SQL Implementation 1970 s 1980 s 1990 s 2000

6 Growth Through Acquisition Creating Best-in-Business Capabilities Oracle FY 2005 Oracle FY 2006 Oracle FY 2007 Oracle FY Acquisitions 17 Acquisitions 14 Acquisitions 8 Acquisitions

7 Oracle s Application Strategy Complete Open Integrated Comprehensive Industry Portfolio Standards-Based Architecture Designed to Work Together More Value Less Complexity More Choice Less Risk More Flexibility Less Cost

8 HSGBU Mission Our Mission is to be the leading strategic supplier of software solutions to pharmaceutical, biotech, medical device, and healthcare companies. We will help them discover, develop, and successfully market innovative products and services to: prevent and cure disease enhance quality of life and meet their shareholder and stakeholder expectations.

9 HSGBU Strategy Our Strategy is to grow to #1 market share for Health Sciences applications among the largest and/or fastest growing pharmaceutical, biotech, medical device, and integrated delivery networks worldwide by offering an integrated application suite sold and supported through a global ecosystem that provides customers with the industry s highest return on investment and best ownership experience. Accelerating Insights for Better Health

10 Oracle Life Sciences Footprint Complete. Open. Integrated. Oracle Partner CRM & Marketing Marketing Loyalty Call Center Sales Order Mgmt Field Service Samples Mgmt Analytics Business Operations Clinical Analytics Clinical Development Pre-Clinical/Discovery Trial Design/Setup Safety Pharmacovigilance Bio-Specimen Mgmt Pre-Clinical Dev Scientific Analytics Trial Operations EDC epro Lab Info Mgmt (LIMS) Scientific Cont. Mgmt Statistical Analysis AMC-Driven Trials Data Integration IVRS Modeling/Simulation Clinical Mfg Data Mgmt/Collaboration Supply Chain Manufacturing Operational Analytics Clinical Data Mgmt Terminology Services Content Mgmt & Regulatory Submission Research Collaboration /Grids PLM Sourcing Warehouse Management Supply Chain Planning Process Mfg Discrete Mfg Process Operations Image Management Clinical Portfolio Mgmt epedigree ERP Corporate Administration EPM Financials Human Resources Compensation Facilities Contracts Procurement HR Help Desk IT Help Desk Infrastructure Integration & Collaboration Enterprise Infrastructure

11 The Growing Industry Interdependence Between Healthcare and Life Sciences Bio-marker discovery Personalized medicine Pharma/ Biotech Adaptive Clinical Trials Healthcare Institutions Research Networks Care Delivery Clinical Research Labs & Biobanks Submissions Safety and Pharmacovigilance

12 Enabling Personalized Medicine Linking Biomedical Research to Healthcare Clinical Trial Sites LIFE SCIENCES SOLUTION INTEGRATED SUITE EDC Safety Innovation Scientific Inference Pharmacovigilance Pharma/ Biotech Clinical Mfg Scientific Analytics Simulation & Modeling Study Design CTMS Submission CRO Laboratory Imaging Data Management Operations Operational Analytics Portfolio Analysis Labs & Biobanks

13 Oracle s Current Clinical Development and Safety Applications Clinical Trial Management (Siebel Clinical) Electronic Data Capture (Oracle Remote Data Capture) Clinical Data Management System (Oracle Clinical) Pharmacovigilance Reporting & Call Center (Oracle Adverse Event Reporting System) Term Classification/Dictionary Management (Oracle Thesaurus Management System) Clinical Integration, Warehousing, & Reporting (Oracle Life Sciences Data Hub)

14

15 China will be Top 5 in Pharmaceutical Market by 2010 Source: The Boston Consulting Group Pharmaceutical market size (US$B) Top E USA 91 USA 150 USA 262 USA 466 Japan 52 Japan 58 Japan 65 Japan 81 Germany 20 Germany 17 Germany 24 Germany 37 France 18 France 17 France 21 France 28 Italy 10 UK 11 UK 16 China 25 Brazil 8.4 Italy 11 Italy 15 UK 24 UK 8.2 China 6.8 China 13 Italy 23 Spain 6.0 Brazil 6.7 Brazil 10 Canada 17 South Korea 4.5 Canada 6.3 Canada 10 Spain 16 Canada 4.3 Spain 6.2 Spain 9.8 Brazil 15 China 4.3

16 China s Changing Pharmaceutical Market Profile Chinese pharmaceuticals market profile % +12% +8% Chinese pharmaceuticals market profile 2010 forecast Patented 9% Branded Generics 14% OTC 15% OTC 23% Patented 21% Generics 62% Generics 37% Branded Generics 19% -25% Source: International Federation of Pharmaceutical Manufacturers Association

17 China Pharmaceutical Market Double digits GDP growth during the past decade year after year Generic drug market share will drop 25% in 10 years from 2000 to 2010 Patented drug market share will grow from 9% to 21% from 2000 to 2010 Huge patient pool, ~250M Strategic, supportive government policies and investments China healthcare market kept a constant growth and a continuous demand for new medicinal products.

18 Health Sciences Global Management Team Neil de Crescenzo GM Sales, Consulting, and Marketing Mike McCann N. America LS Sales Mark McCourt N. America HC Sales Jonathan Best EMEA Sales Leo Liang APAC Sales Chris Ibell Global Consulting Sean Ford Global Marketing Product Management Ramlal Waghray Development Greg Jones Architecture Nick Giannasi LS Product Strategy Penny Lie HC Product Strategy Business Operations Dave Bunker Alliances Kris Joshi Strategy & Business Dev Michele Becci Strategic Accounts Patrick Kesselring Sales Operations

19 Thank you! A Win / Win for You and Us.

20 Thank you! A Win / Win for You and Us.

21 Oracle s HSGBU Clinical Development and Safety Strategy Current Applications NO COMMON PLATFORM AIA & Composite Applications ANALYTICS Next-Generation Integrated Suite (HSS) NEW INTEGRATED SUITE FEATURE SET FOR SINGULAR BUSINESS PROCESSES COMPOSITE APPLICATIONS USING AIA: STUDY DESIGN, INVESTIGATOR PORTAL INTEGRATION PLUS NEW FEATURES FOR END-TO TO-END BUSINESS PROCESSES Go-to-Market Excellence Expand sales, marketing, partner, and consulting infrastructure New license and deployment models